Clinical Trials Directory

Trials / Completed

CompletedNCT00431106

Vinorelbine and Gemcitabine Versus Capecitabine in Pretreated Metastatic Breast Cancer

A Multicenter Randomized Phase III Study of Combination Treatment With Vinorelbine and Gemcitabine Versus Capecitabine Monotherapy in Metastatic Breast Cancer Patients Following Treatment Failure With the Combination of a Taxane and an Anthracycline

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
144 (estimated)
Sponsor
Hellenic Oncology Research Group · Academic / Other
Sex
Female
Age
19 Years – 75 Years
Healthy volunteers
Not accepted

Summary

The combination of vinorelbine and gemcitabine seems to be an important part of the chemotherapy regimens used in metastatic breast cancer patients following treatment failure with the combination of a taxane and an anthracycline. Capecitabine rescue monotherapy in metastatic breast cancer patients following treatment failure with the combination of a taxane and an anthracycline, also seems to be an important part of the chemotherapy regimens used in metastatic breast cancer patients. Whether the combination of vinorelbine and gemcitabine or capecitabine administration is preferable is not yet known, especially in patients with metastatic disease.

Detailed description

This trial will compare the efficacy of combination treatment with Vinorelbine and Gemcitabine versus Capecitabine monotherapy in metastatic breast cancer patients following treatment failure with the combination of a taxane and an anthracycline.

Conditions

Interventions

TypeNameDescription
DRUGGemcitabineGemcitabine at the dose of 1000 mg/m2 intravenously (IV) every 2 weeks for 12 consecutive cycles
DRUGCapecitabineCapecitabine at the dose of 1250 mg/m2 twice daily orally (os), from day 1 to day 14, every 3 weeks for 6 consecutive cycles
DRUGVinorelbineVinorelbine at the dose of 25 mg/m2 IV on day 1 every 2 weeks for 12 consecutive cycles

Timeline

Start date
2002-04-01
Primary completion
2009-01-01
Completion
2009-01-01
First posted
2007-02-05
Last updated
2009-09-28

Locations

10 sites across 1 country: Greece

Source: ClinicalTrials.gov record NCT00431106. Inclusion in this directory is not an endorsement.